Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating levels of ATP is a biomarker of HIV cognitive impairment

3 Dec 2019

Abstract excerpt

Background In developed countries, Human Immunodeficiency Virus type-1 (HIV-1) infection has become a chronic disease despite the positive effects of anti-retroviral therapies (ART), but still at least half of the HIV infected population shown signs of cognitive impairment. Therefore, biomarkers of HIV cognitive decline are urgently needed. Methods We analyze the opening of one of the larger channels expressed by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related cognitive impairment studies
Share to Dementia and Cognitive Impairment Research
Share to HIV Research and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31806564
DOI: 10.1016/j.ebiom.2019.10.029

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating levels of ATP is a biomarker of HIV cognitive impairmentPMID 31806564Read ↗

Extracellular ATP acts on P2Y2 purinergic receptors to facilitate HIV-1 infection.Semantic proximity Read ↗

Peripheral Blood Mononuclear Cells HIV DNA Levels Impact Intermittently on NeurocognitionSemantic proximity Read ↗

The far-reaching HAND of cART: cART effects on astrocytes.Semantic proximity Read ↗

Host single nucleotide polymorphisms and biomarkers of neuronal damage and inflammation in people living with HIV.Semantic proximity Read ↗

Exposure to angiotensin-converting enzyme inhibitors that cross the blood-brain barrier and the risk of dementia among patients with human immunodeficiency virusSemantic proximity Read ↗

Changing clinical phenotypes of HIV-associated neurocognitive disorders.Semantic proximity Read ↗

Prediction of neurological disorders in HIV-infected persons in Taiwan: a nested case-control studySemantic proximity Read ↗

Abundance of Nef and p-Tau217 in Brains of Individuals Diagnosed with HIV-Associated Neurocognitive Disorders Correlate with Disease SeveranceSemantic proximity Read ↗

Endothelial pannexin 1 channels control inflammation by regulating intracellular calciumSemantic proximity Read ↗

Interactions of human immunodeficiency virus‐1 proteins with neurons: possible role in the development of human immunodeficiency virus‐1‐associated dementiaSemantic proximity Read ↗

HIV and FIV glycoproteins increase cellular tau pathology via cGMP-dependent kinase II activationSemantic proximity Read ↗

Reversible dementia in a patient with central nervous system escape of human immunodeficiency virus.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.